2011 Annual Meeting | Controversial Issues in Neurologic Infections
06:30 AM - 07:10 AM |
Steroid Treatment in Herpes Simplex Encephalitis
Avindra Nath, MD, MBBS, FAAN, Israel Steiner, MD |
|
06:30 AM - 08:30 AM |
Break
|
|
07:10 AM - 07:50 AM |
Is There An Infectious Etiology for Multiple Sclerosis?
Avindra Nath, MD, MBBS, FAAN, Andrew R. Pachner, MD |
|
07:50 AM - 08:30 AM |
Natalizumab Is Not Too Risky To Be Used in Multiple Sclerosis
Andrew R. Pachner, MD, Israel Steiner, MD |
Israel Steiner, MD | No disclosure on file |
Avindra Nath, MD, MBBS, FAAN | Dr. Nath has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from ALS Association. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care. |
Andrew R. Pachner, MD | No disclosure on file |